India, Mumbai, Tuesday Nov 10, 2015 - With reference to Notice no: 20151109-43, owing
to amalgamation of Shasun Pharmaceuticals Ltd (Stock Code - 524552) with Strides
Arcolab Ltd., Shasun Pharmaceuticals will be discontinued from trading effective
November 18, 2015 which necessitates its exclusion from various indices.
Indices
|
Drop
|
Add
|
EFFECTIVE FROM
|
|
CODE
|
NAME
|
CODE
|
NAME
|
FFF
|
|
S&P BSE AllCap
|
524552
|
Shasun Pharmaceuticals Ltd.
|
--
|
--
|
--
|
18-Nov-2015
|
S&P BSE 500
|
524552
|
Shasun Pharmaceuticals Ltd.
|
532659
|
IDFC Ltd.
|
0.84
|
S&P BSE Healthcare
|
524552
|
Shasun Pharmaceuticals Ltd.
|
--
|
--
|
--
|
S&P BSE MidSmallCap
|
524552
|
Shasun Pharmaceuticals Ltd.
|
--
|
--
|
--
|
S&P BSE SmallCap
|
524552
|
Shasun Pharmaceuticals Ltd.
|
--
|
--
|
--
|
For any information / clarification, you may contact Index Services on +91 22 2272 5261. You can also write us at index_services@spdji.com
ASIA INDEX PRIVATE LIMITED
Asia Index Pvt. Ltd is a 50-50 partnership between S&P Dow Jones Indices LLC, the world s largest provider of financial market indices, and BSE Ltd, Asia s oldest stock exchange and home to the iconic SENSEX index - a leading indicator of Indian equity market performance. Asia Index Pvt. Ltd, which combines the benchmarks, market intelligence, and insights of both parent companies, each established more than 115 years ago, aims to provide a full array of indices enabling global and domestic investors to participate in South Asia s vibrant economies. The Company is best known for calculating, publishing, and maintaining a diverse family of Asian indices under the umbrella brand, S&P BSE Indices.